Fortis Healthcare shares rise 2.04% on Nifty Midcap 150
Shares of Fortis Healthcare gained 2.04%, trading at Rs 780.15 on Monday. The stock's performance places it among the top gainers on the Nifty Midcap 150 index, with the rise reflecting a positive shift from its previous close, as of 12:19 PM.
Financial Performance:
Fortis Healthcare 's financial performance shows consistent growth in revenue and net profit over the past few years. Here’s an overview of the company’s consolidated financial highlights:
Quarterly Results:
HeadingMar 2024Jun 2024Sep 2024Dec 2024
Mar 2025RevenueRs 1,785.88 CroreRs 1,858.90 CroreRs 1,988.39 CroreRs 1,928.26 Crore
Rs 2,007.20 CroreNet ProfitRs 198.82 CroreRs 173.39 CroreRs 188.85 CroreRs 252.24 Crore
Rs 183.38 CroreEPS2.372.202.343.28
2.44
The company has demonstrated strong quarterly revenue growth, with revenue for the quarter-ending March 2025 reaching Rs 2,007.20 Crore. This represents an increase compared to previous quarters, driven by robust operational performance.
Annual Results:
Heading2021202220232024
2025RevenueRs 4,030.12 CroreRs 5,717.61 CroreRs 6,297.63 CroreRs 6,892.92 Crore
Rs 7,782.75 CroreNet ProfitRs -103.73 CroreRs 765.80 CroreRs 611.15 CroreRs 635.71 Crore
Rs 797.86 CroreEPS-1.457.357.807.93
10.26BVPS88.9892.83107.30113.33
118.11ROE-1.798.988.127.81
8.68Debt to Equity0.190.160.100.11
0.28
The annual revenue for the year ending March 2025 reached Rs 7,782.75 Crore, a notable increase from Rs 6,892.92 Crore in the previous year. The net profit also saw a significant rise, reaching Rs 797.86 Crore for the year ending March 2025. Earnings per share (EPS) have improved to Rs 10.26.
Consolidated Yearly Income Statement:
Mar 2025Mar 2024Mar 2023Mar 2022
Mar 2021Sales7,782 Crores6,892 Crores6,297 Crores5,717 Crores
4,030 CroresOther Income66 Crores38 Crores61 Crores27 Crores
46 CroresTotal Income7,849 Crores6,931 Crores6,359 Crores5,744 Crores
4,076 CroresTotal Expenditure6,669 Crores5,951 Crores5,438 Crores4,634 Crores
3,915 CroresEBIT1,179 Crores979 Crores920 Crores1,110 Crores
161 CroresInterest184 Crores130 Crores129 Crores146 Crores
165 CroresTax197 Crores212 Crores180 Crores197 Crores
99 CroresNet Profit797 Crores635 Crores611 Crores765 Crores
-103 Crores
Consolidated Quarterly Income Statement:
Mar 2025Dec 2024Sep 2024Jun 2024
Mar 2024Sales2,007 Crores1,928 Crores1,988 Crores1,858 Crores
1,785 CroresOther Income19 Crores20 Crores13 Crores13 Crores
9 CroresTotal Income2,027 Crores1,949 Crores2,001 Crores1,871 Crores
1,795 CroresTotal Expenditure1,727 Crores1,626 Crores1,708 Crores1,607 Crores
1,493 CroresEBIT299 Crores322 Crores293 Crores264 Crores
301 CroresInterest67 Crores45 Crores36 Crores35 Crores
34 CroresTax48 Crores25 Crores67 Crores56 Crores
68 CroresNet Profit183 Crores252 Crores188 Crores173 Crores
198 Crores
Cash Flow:
Mar 2025Mar 2024Mar 2023Mar 2022
Mar 2021Operating Activities1,423 Crores1,100 Crores822 Crores865 Crores
485 CroresInvesting Activities-779 Crores-886 Crores-373 Crores-514 Crores
-135 CroresFinancing Activities-713 Crores-86 Crores-471 Crores-517 Crores
-142 CroresOthers0 Crores-2 Crores1 Crores13 Crores
4 CroresNet Cash Flow-69 Crores124 Crores-21 Crores-152 Crores
212 Crores
Balance Sheet:
Mar 2025Mar 2024Mar 2023Mar 2022
Mar 2021Share Capital754 Crores754 Crores754 Crores754 Crores
754 CroresReserves & Surplus8,161 Crores6,906 Crores6,485 Crores5,423 Crores
5,362 CroresCurrent Liabilities1,607 Crores3,170 Crores1,425 Crores1,269 Crores
1,233 CroresOther Liabilities3,167 Crores2,457 Crores3,767 Crores4,437 Crores
3,803 CroresTotal Liabilities13,691 Crores13,288 Crores12,433 Crores11,884 Crores
11,154 CroresFixed Assets6,636 Crores6,221 Crores5,513 Crores5,485 Crores
5,242 CroresCurrent Assets2,164 Crores1,420 Crores1,406 Crores1,133 Crores
1,036 CroresOther Assets4,890 Crores5,646 Crores5,514 Crores5,265 Crores
4,875 CroresTotal Assets13,691 Crores13,288 Crores12,433 Crores11,884 Crores
11,154 CroresContingent Liabilities0 Crores2,999 Crores2,834 Crores2,607 Crores
1,936 Crores
Key Financial Ratios:
RatioMar 2021Mar 2022Mar 2023Mar 2024
Mar 2025Basic EPS (Rs.)-1.457.357.807.93
10.26Diluted Eps (Rs.)-1.457.357.807.93
10.26Book Value [Excl. Reval Reserve]/Share (Rs.)88.9892.83107.30113.33
118.11Dividend/Share (Rs.)0.000.001.001.00
1.00Face Value10101010
10Gross Profit Margin (%)11.1919.1718.4618.94
21.26Operating Margin (%)3.9813.9113.4513.97
16.30Net Profit Margin (%)-2.5713.399.709.22
10.25Return on Networth / Equity (%)-1.798.988.127.81
8.68ROCE (%)1.617.497.699.52
10.50Return On Assets (%)-0.984.674.734.50
5.65Current Ratio (X)0.840.890.990.45
1.35Quick Ratio (X)0.780.800.900.41
1.27Debt to Equity (x)0.190.160.100.11
0.28Interest Coverage Ratios (X)0.977.479.019.97
8.97Asset Turnover Ratio (%)36.120.080.090.54
0.58Inventory Turnover Ratio (X)52.500.000.000.00
0.003 Yr CAGR Sales (%)-6.0013.1116.6030.78
16.673 Yr CAGR Net Profit (%)-67.5914.11177.58147.56
2.07P/E (x)-137.3439.5133.3252.99
68.07P/B (x)2.453.552.714.14
5.91EV/EBITDA (x)36.2621.2617.9025.16
33.21P/S (x)3.733.833.124.60
6.78
Corporate Actions:
Fortis Healthcare has announced several corporate actions, including newspaper publications regarding the 29th Annual General Meeting. These announcements provide important updates to shareholders regarding company activities and governance.
The company announced a final dividend of Rs 1.00 per share (10%) for the years 2023, 2024 and 2025.
Fortis Healthcare had a rights issue with announcement date 2009-08-10, existing ratio of 5 and offered ratio of 2, with face value of 10 and premium of 100. Record date was 2009-08-20 and rights ratio was 2:5.
Another rights issue with announcement date 2008-12-24, existing ratio of 5 and offered ratio of 2, with face value of 10 and premium of 100. Exrights date was 18 Aug, 2009 and rights ratio was 2:5.Overall, Fortis Healthcare demonstrates a positive growth trajectory, driven by consistent financial performance and shareholder-friendly corporate actions.